Syndicate content

Archive - Page

April 23rd, 2009

About Us


Michael D. O'Neill, MA (Microbiology & Immunology, Duke University)


Alex Andrus, PhD, JD (Patent Attorney, Genentech)
Kazako Aoyagi, PhD (Senior Director, Business Development, Celerion)
Philip Askenase, MD (Professor of Medicine-Immunology, Yale School of Medicine)
Leonora Balaj, PhD (Harvard, MGH)
Ben Zane Cohen, MD (Ophthalmologist)
Patricia Dahl (CEO/Executive Director, Eye Bank for Sight Restoration, New York City)
Rachel DeRita, PhD candidate (Thomas Jefferson University, Department of Cancer Biology)
Dolores Di Vizio, MD, PhD (Cedars-Sinai Medical Center)
Erika Ebbel, PhD (CEO, Ixcela; Founder & Executive Director, Science from Scientists)
Ronald Faanes, PhD (Past Head, Immunology, Boerhinger-Ingelheim)
Bert Fisher, PhD (Principal & Founding Member, Lithochimeia, Inc.)
Richard A. Gatti, MD (Professor-in-Residence, Human Genetics, UCLA)
Michael A. Goldman, PhD (Professor & Chair, Biology, San Francisco State University)
Charles Halasz, MD (Associate Clinical Professor, Dermatology, Columbia University, New York)
Elaine Heron, PhD (Director, BioMarin Pharmaceutical; Past Chairman, Amplyx Pharmaceuticals)
Andrew Hill, PhD (Professor & Department Head, La Trobe University; President, ISEV))

April 22nd


This is the news page

March 30th

March 5th

Content Page

Page of Content